Glaucoma screening for at-risk Californians
Part of Eyes & vision clinical trials.
This study tests whether offering eye exams at a health center helps find glaucoma early in people who are at higher risk. It may help you catch vision problems before they get worse.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are Black and 50 years or older, or Hispanic and 65 years or older, or you have diabetes and are 50 years or older
- You have been seen at a participating health center (Federally Qualified Health Center) in the last month
- You have a working phone number and mailing address
- You have not had an eye exam with an optometrist in the past year
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses an AI tool to screen for glaucoma at community health centers. If you qualify, you will get a free eye check to catch glaucoma early and help researchers improve screening for high-risk groups.
This trial offers eye screening for glaucoma in adults between 55 and 65 who live in specific local healthcare areas. The goal is to see how well the screening process works and improves identification of people who may have glaucoma.
This study uses a special imaging test (OCT angiography) to look at blood flow around the optic nerve in people with advanced glaucoma. It aims to better understand how glaucoma affects eye circulation, which may help improve future care.
This study tests new ways to diagnose glaucoma (and sometimes related eye conditions) using eye exams and measurements. It may help improve how doctors detect glaucoma earlier and more accurately.
This study tests if telemedicine can help find glaucoma and other eye problems early. It may help people who speak one of several languages and want to check their eye health from home.
This study tests a new algorithm to help screen for glaucoma in people of African descent. It aims to improve early detection and diagnosis.
Hear when a new Glaucoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.